$6.14 Billion is the total value of ValueAct Holdings's 9 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 22.2% .
|KKR||Sell||KKR & CO INC||$1,078,510,437|
|STX||SEAGATE TECHNOLOGY HLDNGS PL||$888,459,068|
|CBRE||CBRE GROUP INCcl a||$672,397,729|
|NSIT||Buy||INSIGHT ENTERPRISES INC||$644,909,143|
|NYT||Sell||NEW YORK TIMES COcl a||$521,402,340|
|SPOT||New||SPOTIFY TECHNOLOGY S A||$300,530,220||–||2,249,141|
|ALTUS POWER INC||$22,016,492|
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
The EDGAR filing(s) were signed by:
About ValueAct Holdings
ValueAct Holdings is a San Francisco-based investment firm that specializes in acquiring significant stakes in undervalued companies and working with management to improve their performance. The firm was founded in 2000 by Jeffrey Ubben, who previously worked at Fidelity Investments and Blum Capital Partners.
ValueAct Holdings has a long-term investment approach and typically holds its positions for several years. The firm has a concentrated portfolio of around 10-15 investments, which allows it to focus its resources and expertise on a select group of companies.
One of ValueAct Holdings' most notable investments is in Microsoft, where the firm has been a shareholder since 2013. ValueAct Holdings initially acquired a $2 billion stake in the company and worked with management to shift the company's focus towards cloud computing and subscription-based services. The firm has since sold a portion of its stake but remains one of Microsoft's largest shareholders.
Other notable investments by ValueAct Holdings include Adobe, Valeant Pharmaceuticals, and Rolls-Royce Holdings. The firm has also been active in the financial services sector, with investments in Morgan Stanley, KKR & Co., and AllianceBernstein.
Jeffrey Ubben stepped down as CEO of ValueAct Holdings in 2020 and was succeeded by Mason Morfit, who had previously served as the firm's president and chief investment officer. Under Morfit's leadership, ValueAct Holdings is expected to continue its focus on long-term value creation and constructive engagement with portfolio companies.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
|Name||Quarters owned||Latest quarter owned||Max weighting|
|CBRE GROUP INC||40||Q1 2023||13.4%|
|TRINITY INDUSTRIES INC||25||Q2 2022||8.3%|
|VALEANT PHARMACEUTICALS INTE||21||Q2 2018||21.3%|
|KKR & CO LP||20||Q1 2023||21.7%|
|CITIGROUP INC||20||Q3 2022||23.0%|
|SEAGATE TECHNOLOGY PLC||20||Q1 2021||22.1%|
|ARMSTRONG WORLD INDUSTRIES||20||Q1 2019||5.6%|
|MICROSOFT CORP||19||Q4 2017||31.2%|
|MORGAN STANLEY||19||Q4 2020||13.0%|
|SLM CORP||18||Q2 2022||5.5%|
View ValueAct Holdings's complete holdings history.
View ValueAct Holdings's complete filings history.
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.